Skip to content
10-K

Annual Report

Doximity, Inc. DOCS

0001516513-25-000056

← back to feed
Filed
May 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 31, 2024 186.56M sh
Cash And Equivalents FY 2025 · Mar 31, 2024 $96.79M
Current Liabilities FY 2025 · Mar 31, 2024 $147.25M
Total Liabilities FY 2025 · Mar 31, 2024 $177.98M
Current Assets FY 2025 · Mar 31, 2024 $912.94M
Total Assets FY 2025 · Mar 31, 2024 $1.08B
Shares Diluted FY 2025 · Mar 31, 2023 213.43M sh
Stock Repurchased FY 2025 · Mar 31, 2023 $85.32M
Capex FY 2025 · Mar 31, 2023 $1.7M
Operating Cash Flow FY 2025 · Mar 31, 2023 $179.6M
Eps Diluted FY 2025 · Mar 31, 2023 $0.53
Eps Basic FY 2025 · Mar 31, 2023 $0.58
Sga Expense FY 2025 · Mar 31, 2023 $36.75M
Rd Expense FY 2025 · Mar 31, 2023 $80.19M
Net Income FY 2025 · Mar 31, 2023 $112.82M
Operating Income FY 2025 · Mar 31, 2023 $125.11M
Gross Profit FY 2025 · Mar 31, 2023 $365.56M
Cost Of Revenue FY 2025 · Mar 31, 2023 $53.49M
Revenue FY 2025 · Mar 31, 2023 $419.05M
Stockholders Equity FY 2025 · Mar 31, 2022 $878.59M